Logo image of EPH.MI

EPH SPA (EPH.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:EPH - IT0005623845 - Common Stock

0.126 EUR
-0.02 (-12.2%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

0

EPH gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 13 industry peers in the Broadline Retail industry. EPH has a bad profitability rating. Also its financial health evaluation is rather negative. EPH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year EPH has reported negative net income.
  • In the past year EPH has reported a negative cash flow from operations.
  • In the past 5 years EPH always reported negative net income.
  • In the past 5 years EPH always reported negative operating cash flow.
EPH.MI Yearly Net Income VS EBIT VS OCF VS FCFEPH.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • EPH has a Return On Assets of 141.53%. This is amongst the best in the industry. EPH outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 141.53%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPH.MI Yearly ROA, ROE, ROICEPH.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPH.MI Yearly Profit, Operating, Gross MarginsEPH.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

  • EPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EPH.MI Yearly Shares OutstandingEPH.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022
EPH.MI Yearly Total Debt VS Total AssetsEPH.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -213.64, we must say that EPH is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -213.64, EPH is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -213.64
ROIC/WACCN/A
WACCN/A
EPH.MI Yearly LT Debt VS Equity VS FCFEPH.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 0.02 indicates that EPH may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.02, EPH is doing worse than 92.31% of the companies in the same industry.
  • A Quick Ratio of 0.02 indicates that EPH may have some problems paying its short term obligations.
  • EPH has a worse Quick ratio (0.02) than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
EPH.MI Yearly Current Assets VS Current LiabilitesEPH.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.48% over the past year.
EPS 1Y (TTM)97.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPH.MI Yearly Revenue VS EstimatesEPH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2020 2021 2022 50M 100M 150M 200M
EPH.MI Yearly EPS VS EstimatesEPH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -500M -1B -1.5B -2B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • EPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPH.MI Price Earnings VS Forward Price EarningsEPH.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPH.MI Per share dataEPH.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -10K -20K -30K -40K -50K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for EPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

EPH SPA

BIT:EPH (1/16/2026, 7:00:00 PM)

0.126

-0.02 (-12.2%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)09-16
Earnings (Next)04-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.92%
Ins Owner ChangeN/A
Market Cap830.34K
Revenue(TTM)N/A
Net Income(TTM)313.20K
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-50736.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS-1.75
TBVpS-1.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 141.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -213.64
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1372.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.57%
OCF growth 3YN/A
OCF growth 5YN/A

EPH SPA / EPH.MI FAQ

What is the fundamental rating for EPH stock?

ChartMill assigns a fundamental rating of 0 / 10 to EPH.MI.


What is the valuation status for EPH stock?

ChartMill assigns a valuation rating of 0 / 10 to EPH SPA (EPH.MI). This can be considered as Overvalued.


What is the profitability of EPH stock?

EPH SPA (EPH.MI) has a profitability rating of 1 / 10.